COSMOS Pharmaceutical Cor... (CSMYF)

AI Score

Unlock

46.06

-0.10 (-0.22%)

At close: Apr 24, 2025, 8:00 PM

COSMOS Pharmaceutical Balance Sheet Statement

Financials in JPY. Fiscal year is June - May.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	May 31, 2024	May 31, 2023	May 31, 2022	May 31, 2021	May 31, 2020	May 31, 2019	May 31, 2018	May 31, 2017	May 31, 2016
Cash & Equivalents	52.3B	45.93B	37.36B	55.11B	52.12B	19.02B	21.67B	27.73B	27.28B
Short-Term Investments	n/a	-4.31B	-4.17B	-17.06B	-17.04B	-16.91B	-16.15B	-15.41B	-15.19B
Long-Term Investments	n/a	4.31B	4.18B	17.07B	17.04B	16.91B	16.16B	15.41B	15.19B
Other Long-Term Assets	25.92B	2.1B	1.97B	1.77B	1.77B	1.75B	1.68B	1.6B	1.5B
Receivables	12.2B	12.65B	10.77B	8.56B	7.7B	398M	91M	22M	28M
Inventory	86.17B	77.48B	66.36B	60.55B	53.56B	53.29B	48.75B	40.04B	38.23B
Other Current Assets	12.65B	10.8B	9.36B	7.42B	6.54B	5.94B	5.91B	4.57B	4.09B
Total Current Assets	154.33B	137.09B	115.47B	125.13B	114.15B	80.39B	78.07B	73.75B	70.91B
Property-Plant & Equipment	295.8B	274.65B	239.03B	195.13B	185.37B	172.82B	153.98B	134.45B	114.46B
Goodwill & Intangibles	497M	547M	433M	326M	268M	287M	295M	215M	332M
Total Long-Term Assets	322.21B	283.88B	247.58B	216.19B	206.13B	193.17B	172.53B	151.94B	131.69B
Total Assets	476.55B	420.97B	363.05B	341.32B	320.28B	273.56B	250.61B	225.69B	202.59B
Account Payables	179.55B	161.85B	139.22B	133.04B	136.53B	110.8B	105.06B	91.73B	82.47B
Deferred Revenue	n/a	24.8B	18.98B	22.18B	20.79B	18.12B	15.54B	15.33B	13.85B
Short-Term Debt	4.58B	2.74B	1.39B	1.49B	1.49B	1.49B	3.2B	4.49B	4.95B
Other Current Liabilities	19.11B	18.44B	13.55B	18.04B	17.02B	14.75B	12.09B	12.45B	11.28B
Total Current Liabilities	213.23B	192.05B	162.06B	159.54B	161.95B	133.17B	126.44B	114.13B	103.46B
Long-Term Debt	23.39B	10.02B	3B	4.09B	5.57B	7.06B	8.55B	11.75B	16.23B
Other Long-Term Liabilities	4.33B	4.13B	4.13B	3.85B	3.63B	3.4B	3.11B	3B	2.86B
Total Long-Term Liabilities	31.88B	17.84B	10.48B	11.2B	12.66B	14.1B	15.29B	18.51B	22.96B
Total Liabilities	245.1B	209.9B	172.54B	170.74B	174.61B	147.27B	141.72B	132.64B	126.42B
Total Debt	34.06B	18.2B	9.41B	10.44B	12.12B	13.88B	17.2B	21.77B	26.67B
Common Stock	4.18B	4.18B	4.18B	4.18B	4.18B	4.18B	4.18B	4.18B	4.18B
Retained Earnings	222.28B	202.49B	181.95B	162.06B	137.19B	117.83B	100.43B	84.58B	67.75B
Comprehensive Income	n/a	40M	5M	-38M	-61M	-91M	-89M	-73M	-117M
Shareholders Equity	231.44B	211.07B	190.51B	170.58B	145.68B	126.29B	108.89B	93.05B	76.18B
Total Investments	4.39B	4M	4M	5M	5M	4M	5M	4M	8M